A number of other equities analysts have also commented on the company. Stifel Nicolaus set a $55.00 price objective on Ventas and gave the stock a hold rating in a research note on Monday. ValuEngine upgraded Ventas from a sell rating to a hold rating in a research note on Wednesday, October 17th. Royal Bank of Canada set a $61.00 price objective on Ventas and gave the stock a buy rating in a research note on Tuesday, July 31st. SunTrust Banks reiterated a hold rating and issued a $58.00 price objective on shares of Ventas in a research note on Tuesday, July 31st. Finally, Cantor Fitzgerald reiterated a hold rating and issued a $56.00 price objective on shares of Ventas in a research note on Friday, July 27th. Four equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and three have assigned a buy rating to the company’s stock. Ventas has a consensus rating of Hold and an average target price of $55.62.
Ventas stock opened at $57.26 on Friday. The company has a debt-to-equity ratio of 1.00, a quick ratio of 0.56 and a current ratio of 0.56. The stock has a market capitalization of $20.24 billion, a PE ratio of 13.76, a price-to-earnings-growth ratio of 3.87 and a beta of 0.14. Ventas has a 52 week low of $46.55 and a 52 week high of $65.72.
The company also recently announced a quarterly dividend, which was paid on Friday, October 12th. Investors of record on Monday, October 1st were given a dividend of $0.79 per share. This represents a $3.16 dividend on an annualized basis and a yield of 5.52%. The ex-dividend date of this dividend was Friday, September 28th. Ventas’s dividend payout ratio (DPR) is presently 75.96%.
In related news, EVP T Richard Riney sold 13,708 shares of Ventas stock in a transaction dated Friday, August 31st. The stock was sold at an average price of $60.00, for a total transaction of $822,480.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 1.40% of the stock is owned by company insiders.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Legacy Advisors LLC boosted its holdings in Ventas by 5,960.6% during the second quarter. Legacy Advisors LLC now owns 2,000 shares of the real estate investment trust’s stock valued at $115,000 after purchasing an additional 1,967 shares in the last quarter. Howe & Rusling Inc. boosted its holdings in Ventas by 591.7% during the second quarter. Howe & Rusling Inc. now owns 2,338 shares of the real estate investment trust’s stock valued at $133,000 after purchasing an additional 2,000 shares in the last quarter. Steward Partners Investment Advisory LLC boosted its holdings in Ventas by 354.7% during the second quarter. Steward Partners Investment Advisory LLC now owns 3,001 shares of the real estate investment trust’s stock valued at $171,000 after purchasing an additional 2,341 shares in the last quarter. Signaturefd LLC boosted its holdings in Ventas by 83.9% during the second quarter. Signaturefd LLC now owns 3,043 shares of the real estate investment trust’s stock valued at $173,000 after purchasing an additional 1,388 shares in the last quarter. Finally, Bay Colony Advisory Group Inc d b a Bay Colony Advisors acquired a new stake in Ventas during the second quarter valued at approximately $188,000. 84.40% of the stock is currently owned by institutional investors.
Ventas Company Profile
Ventas, Inc, an S&P 500 company, is a leading real estate investment trust. Its diverse portfolio of approximately 1,200 assets in the United States, Canada and the United Kingdom consists of seniors housing communities, medical office buildings, life science and innovation centers, inpatient rehabilitation and long-term acute care facilities, health systems and skilled nursing facilities.
Recommended Story: Do stock splits help investors?
Receive News & Ratings for Ventas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ventas and related companies with MarketBeat.com's FREE daily email newsletter.